Clinical Trial Update: Palbociclib and Cetuximab in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of the combination palbociclib and cetuximab for metastatic colorectal cancer has completed and results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• IBRANCE (PALBOCICLIB)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Cancer of the Colon, Colon Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-07